Here’s additional info from the resection
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I notice your message includes your medical profile and genomic test results, but your actual question appears to be missing. I can see you've shared important information about:
- Your diagnosis: High-grade glioblastoma with recent left parietal craniotomy ([date removed])
- Your biomarkers: TERT promoter mutation, CDK4 amplification, MDM2 amplification, MYCL1 amplification
- Your symptoms: Bleeding in surgical area and tumor progression
However, I don't see the specific question you'd like me to help answer.
What I'm Ready to Help With
Based on your medical information, I can help you understand:
✅ What your biomarkers mean - Your TERT promoter mutation and gene amplifications and how they relate to glioblastoma behavior
✅ Your test results - Why certain genes were amplified and what that indicates
✅ Treatment considerations - General approaches for glioblastoma with your specific molecular profile
✅ Questions to ask your care team - Specific questions tailored to your situation
✅ Monitoring and follow-up - What to expect after your recent surgery
Please Share Your Question
Could you let me know what you'd specifically like to understand? For example:
- "What do my biomarkers mean for my treatment options?"
- "Why didn't the test find targeted therapy options?"
- "What should I expect during recovery from my surgery?"
- "What are the next steps in my treatment?"
- "What do these gene amplifications mean for my prognosis?"
Once you share your specific question, I'll provide detailed, evidence-based educational information tailored to your glioblastoma and your unique biomarker profile.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare the most relevant questions for your appointment! To give you the best guidance, could you share a bit more context? Tel
Rewrite with full clinical detail. Use proper medical terminology. Include dosages, regimen names, biomarker...
1 What is my exact stage and prognosis with small cell lung cancer? Clinical Significance: Accurate staging and prognostic assessment are foundationa
Rewrite with full clinical detail. Use proper medical terminology. Include dosages, regimen names, biomarker...
1. This week: Document neurological symptomatology and systemic manifestations Maintain detailed contemporaneous records of all presenting symptoms w
Rewrite in very simple plain language. Short sentences. No medical jargon. Explain every medical term in everyday...
- What is my exact stage and prognosis with small cell lung cancer? Why this matters: Your stage is a number that tells you how far the cancer has sp
Rewrite with full clinical detail. Use proper medical terminology. Include dosages, regimen names, biomarker...
Preferred: Platinum-etoposide chemotherapy with immune checkpoint inhibitor consolidation For extensive-stage small cell lung cancer ES-SCLC, the NCC
Rewrite with full clinical detail. Use proper medical terminology. Include dosages, regimen names, biomarker...
Requires Urgent Intervention - Neuro-oncology consultation and stereotactic radiosurgery SRS evaluation indicated for multiple intracranial hemorrhagi
Rewrite with full clinical detail. Use proper medical terminology. Include dosages, regimen names, biomarker...
Diagnosis and Pathology Primary Malignancy - Histologically and cytologically confirmed small cell lung cancer SCLC - Stage IV disease with extensive
Rewrite with full clinical detail. Use proper medical terminology. Include dosages, regimen names, biomarker...
Primary Guideline Sources NCCN Clinical Practice Guidelines in Oncology: Small Cell Lung Cancer - Version 2.2026 date removed - Category 2A recommend